CS logo
small CS logo
Oncology Specialties, PC; Clearview Cancer Institute

Huntsville, Alabama, United States
Cancer treatment center in Huntsville, Alabama
3601 Cci Dr NW, Huntsville, AL 35805

About Oncology Specialties, PC; Clearview Cancer Institute


"Clearview Cancer Institute is north Alabamas leading cancer treatment center. For over 30 years we've provided leading-edge treatment & compassion."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Celgene
5
BeiGene
1
Biodesix, Inc.
1
EGEN, Inc.
1
EMD Serono Research & Development Institute, Inc.
1
Jazz Pharmaceuticals
1
Morphotek
1
Pharmacyclics LLC.
1
Regeneron Pharmaceuticals
1
Total Rows: 9

Clinical Trials at Oncology Specialties, PC; Clearview Cancer Institute


During the past decade, Oncology Specialties, PC; Clearview Cancer Institute conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1111001122001100000011001100Started TrialsCompleted Trails20152016201720182019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian Cancer
2007-04-01
2009-11-01
Completed
13
Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer
2007-11-01
2013-02-01
Completed
1,052
Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse
2009-04-16
2013-04-12
Terminated
1,100
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
2011-07-18
2015-06-26
Completed
113
Connect® Myeloid Disease Registry
2013-12-12
2031-03-31
Recruiting
2,300
Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma
2012-12-28
2019-01-23
Completed
20
Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer
2014-02-11
2019-08-01
Completed
427
Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE)
2015-05-01
2019-04-25
Completed
430

Rows per page:

1–13 of 13

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Oncology Specialties, PC; Clearview Cancer Institute" #1 sponsor was "Celgene" with 5 trials, followed by "BeiGene" with 1 trials sponsored, "Biodesix, Inc." with 1 trials sponsored, "EGEN, Inc." with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Specialties, PC; Clearview Cancer Institute" #1 collaborator was "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "The Leukemia and Lymphoma Society" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsCelgene: 5Celgene: 5BeiGene: 1BeiGene: 1Biodesix, Inc.: 1Biodesix, Inc.: 1EGEN, Inc.: 1EGEN, Inc.: 1EMD Serono Research &Development Institute,Inc.: 1EMD Serono Research &Development Institute,Inc.: 1Jazz Pharmaceuticals: 1Jazz Pharmaceuticals: 1Morphotek: 1Morphotek: 1Pharmacyclics LLC.: 1Pharmacyclics LLC.: 1Regeneron Pharmaceuticals: 1Regeneron Pharmaceuticals: 1

Created with Highcharts 11.1.0Top CollaboratorsEisai Europe Ltd.(United Kingdom): 1Eisai Europe Ltd.(United Kingdom): 1Merck KGaA,Darmstadt, Germany: 1Merck KGaA,Darmstadt, Germany: 1The Leukemia andLymphoma Society: 1The Leukemia andLymphoma Society: 1

Clinical Trials Conditions at Oncology Specialties, PC; Clearview Cancer Institute


According to Clinical.Site data, the most researched conditions in "Oncology Specialties, PC; Clearview Cancer Institute" are "Waldenstrom Macroglobulinemia" (2 trials), "B Cell Non-Hodgkin's Lymphoma" (1 trials), "Basal Cell Carcinoma" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma" (1 trials). Many other conditions were trialed in "Oncology Specialties, PC; Clearview Cancer Institute" in a lesser frequency.

Clinical Trials Intervention Types at Oncology Specialties, PC; Clearview Cancer Institute


Most popular intervention types in "Oncology Specialties, PC; Clearview Cancer Institute" are "Drug" (10 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "AVL-292" (1 trials), "Abraxane (Induction)" (1 trials), "Abraxane (Maintenance)" (1 trials) and "Albumin-bound paclitaxel" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Oncology Specialties, PC; Clearview Cancer Institute


The vast majority of trials in "Oncology Specialties, PC; Clearview Cancer Institute" are 11 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Oncology Specialties, PC; Clearview Cancer Institute


Currently, there are NaN active trials in "Oncology Specialties, PC; Clearview Cancer Institute". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Oncology Specialties, PC; Clearview Cancer Institute, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Oncology Specialties, PC; Clearview Cancer Institute, 3 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5Phase 1: 3Phase 1: 3Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 6Completed: 6Recruiting: 5Recruiting: 5Active, not recruiting: 1Active, not recruiting: 1Terminated: 1Terminated: 1

Departments of Oncology Specialties, PC; Clearview Cancer Institute


Oncology Specialties, PC; Clearview Cancer Institute has several departments that took part in Clinical trials: "Clearview Cancer Institute" - 103 trials
Departments List
Name
City
Trials
Total Rows: 1